Dibencozide
Dibencozide (adenosylcobalamin) is one of two active coenzyme forms of vitamin B12 — the one used inside mitochondria. It corrects B12 deficiency just like cyanocobalamin, methylcobalamin, and hydroxocobalamin. There is NO controlled head-to-head trial showing that dibencozide outperforms other B12 forms for fatigue, energy, or any clinical outcome. The 'active coenzyme form' marketing claim is biochemistry, not clinical-trial evidence.
Quick decision guide
May help most
Correcting documented vitamin B12 deficiency. People who prefer a 'no-cyanide' form (cyanocobalamin releases a microgram of cyanide on conversion — clinically inconsequential in most adults but a marketing differentiator).
Common dosing range
1,000–5,000 mcg/day sublingual or oral. For pernicious anemia or strict vegan deficiency, 1,000 mcg/day oral is well-established as effective via passive diffusion even without intrinsic factor.
When to expect effects
Energy and neurological symptoms improve over 1–8 weeks of repletion; megaloblastic anemia corrects over 1–3 months; severe neurological damage may not fully reverse.
Watch out for
If your symptoms persist after B12 repletion has restored serum B12 and MMA to normal, the cause is not B12 deficiency. Don't keep escalating dose chasing 'energy.'
Evidence snapshot
What is it
Dibencozide (also called adenosylcobalamin or coenzyme B12) is one of the two active coenzyme forms of vitamin B12 in the body. It is the form used inside mitochondria for energy metabolism and is the form of B12 stored in the liver.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
Vitamin B12 deficiency repletion Strong Evidence | Normalization of serum B12, MMA, and homocysteine over 1–8 weeks; reticulocyte response within days for megaloblastic anemia | Adults with lab-documented B12 deficiency, strict vegans, post-bariatric patients, those on long-term PPI/metformin, older adults with food-bound malabsorption | Reticulocytosis within days; symptomatic improvement 1–8 weeks; neurological recovery 3–12 months |
Energy / fatigue in B12-deficient adults Good Evidence | Marked improvement in deficiency-related fatigue with repletion to normal B12 levels; minimal/no effect in non-deficient adults | Adults with documented B12 deficiency and fatigue as a presenting symptom | 1–8 weeks for deficiency-related fatigue |
Methylmalonic acidemia (rare inborn metabolic disease) Good Evidence | Reduction in plasma methylmalonic acid in responsive MMA genotypes; biochemical and clinical improvement specific to those subtypes | Pediatric and adult patients with diagnosed methylmalonic acidemia under specialist care | Biochemical response within days; ongoing therapeutic use lifelong |
Vitamin B12 deficiency repletion
- Effect
- Normalization of serum B12, MMA, and homocysteine over 1–8 weeks; reticulocyte response within days for megaloblastic anemia
- Best fit
- Adults with lab-documented B12 deficiency, strict vegans, post-bariatric patients, those on long-term PPI/metformin, older adults with food-bound malabsorption
- Time
- Reticulocytosis within days; symptomatic improvement 1–8 weeks; neurological recovery 3–12 months
Energy / fatigue in B12-deficient adults
- Effect
- Marked improvement in deficiency-related fatigue with repletion to normal B12 levels; minimal/no effect in non-deficient adults
- Best fit
- Adults with documented B12 deficiency and fatigue as a presenting symptom
- Time
- 1–8 weeks for deficiency-related fatigue
Methylmalonic acidemia (rare inborn metabolic disease)
- Effect
- Reduction in plasma methylmalonic acid in responsive MMA genotypes; biochemical and clinical improvement specific to those subtypes
- Best fit
- Pediatric and adult patients with diagnosed methylmalonic acidemia under specialist care
- Time
- Biochemical response within days; ongoing therapeutic use lifelong
Evidence for 3 uses
AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.
Vitamin B12 deficiency repletion
Corrects deficiencyB12 deficiency causes megaloblastic anemia, peripheral neuropathy, subacute combined degeneration of the spinal cord, fatigue, glossitis, and cognitive symptoms. Repletion with any oral B12 form — cyanocobalamin, methylcobalamin, hydroxocobalamin, or adenosylcobalamin (dibencozide) — corrects the deficiency provided the dose is adequate and absorption is not totally blocked. High-dose oral (1,000–2,000 mcg/day) achieves blood levels comparable to IM injection in most patients including those with pernicious anemia. Dibencozide is one valid choice in this class; it is not demonstrably better than the others.
Bottom line: Effective for repletion. Form choice is largely marketing — get whichever you prefer at an adequate dose.
Energy / fatigue in B12-deficient adults
Corrects deficiencyFatigue from B12 deficiency improves with B12 repletion — this is one of the most reliable observations in nutritional medicine. The signal in NON-deficient adults is much weaker: repleting normal levels to 'supranormal' doesn't reliably produce more energy. Dibencozide marketing specifically emphasizes 'mitochondrial energy production' because adenosylcobalamin is the coenzyme in branched-chain amino acid catabolism (methylmalonyl-CoA mutase), but no controlled trials show better fatigue outcomes from dibencozide vs cyanocobalamin in B12-deficient patients.
Bottom line: If you're deficient, B12 helps. If you're not, supranormal dosing of any form (dibencozide included) does not reliably increase energy.
Methylmalonic acidemia (rare inborn metabolic disease)
Corrects deficiencyIn the rare inherited disorder methylmalonic acidemia (MMA), the methylmalonyl-CoA mutase enzyme is deficient. Some MMA subtypes (mut-, cblA, cblB) respond to high-dose adenosylcobalamin specifically because the missing cofactor is exactly what dibencozide supplies. This is a clinical genetics indication managed by metabolic disease specialists, not a consumer supplement use, but it is the one place where adenosylcobalamin's mitochondrial specificity is uniquely relevant.
Bottom line: The narrow rare-disease indication where adenosylcobalamin is genuinely the preferred form. Managed by metabolic genetics specialists.
How it works
How to take it
What to track
Bottom line: Get a lab first. If deficient, 1,000–5,000 mcg/day oral or sublingual dibencozide is a reasonable form choice. Recheck B12 and MMA after 8–12 weeks to confirm repletion.
5 commercial forms
Compare the main delivery options and what they’re best suited for.
Sublingual dibencozide
Common supplementAdenosylcobalamin in a tablet or lozenge held under the tongue for 30–60 seconds before swallowing. Marketed for improved absorption via the oral mucosa, though most absorbed B12 still comes from the GI tract. Standard doses 1,000–5,000 mcg per tablet.
Mucosal absorption is modest; the bulk of absorbed B12 still comes from intestinal uptake.
Oral capsule / tablet dibencozide
SimplestStandard oral form. Absorbs via intrinsic-factor pathway (~50% at 1 mcg) and passive diffusion (~1% of dose at supraphysiologic intakes). 1,000+ mcg per day reliably corrects deficiency even when intrinsic factor is absent.
Reliable repletion at 1,000+ mcg/day even in pernicious anemia.
Methylcobalamin (sister coenzyme form)
CompareThe cytoplasmic active form of B12, used by methionine synthase. Often marketed alongside or instead of adenosylcobalamin. Neither has shown clinically meaningful superiority over the other or over plain cyanocobalamin in head-to-head trials. Choice between methyl and adenosyl is largely preference.
Equivalent repletion of B12 status; theoretical preference of methyl form for methylation pathway / adenosyl form for mitochondrial pathway is biochemistry-driven, not RCT-driven.
Hydroxocobalamin (injectable preferred form)
MedicalUsed in IM injections by clinicians, especially for cyanide poisoning treatment (it binds cyanide). Longer plasma half-life than cyanocobalamin. Not commonly sold as an oral consumer supplement.
IM is the standard delivery; long retention compared to other forms.
Cyanocobalamin (cheapest form)
Most studiedThe synthetic form used in most low-cost B12 supplements and fortified foods. Stable, well-absorbed, and effective for repletion. Contains a small cyanide moiety that is released and detoxified during intracellular conversion (clinically inconsequential in adults with normal kidney function). The 'no cyanide' marketing of other forms is the differentiator here.
The form used in most RCT evidence; reliably corrects deficiency.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Masking of folate deficiency: high-dose B12 can correct the megaloblastic anemia caused by folate deficiency without correcting the underlying folate problem, allowing neurological damage to progress. Lab work should include folate when investigating macrocytosis.
Polycythemia vera and Leber's hereditary optic neuropathy are theoretical contraindications to high-dose B12 of any form — discuss with your hematologist or neuro-ophthalmologist before starting.
Allergic reactions: rare with oral cobalamins; injectable cobalamin reactions are usually to excipients rather than the active ingredient. No specific dibencozide allergy pattern.
Persistent symptoms despite repletion: if fatigue, neuropathy, or cognitive symptoms persist after B12 and MMA have normalized, the cause is not B12 deficiency. Don't keep escalating dose chasing symptoms — investigate other causes.
Who should avoid it
- People with confirmed Leber's hereditary optic neuropathy (LHON) — historic concern about precipitating optic atrophy; discuss with your specialist.
- People with cobalt allergy (rare).
- Avoid as 'self-treatment' if you have unexplained macrocytic anemia or progressive neurological symptoms — get a clinician evaluation first, because masking folate deficiency or other causes is harmful.
Pregnancy & breastfeeding
Pregnancy RDA is 2.6 mcg/day; lactation 2.8 mcg/day. Supplemental B12 is safe in pregnancy at standard prenatal doses; deficiency is harmful to fetal neurological development. Vegan pregnant women should ensure reliable B12 intake (at least 250 mcg/day supplemental of any form including dibencozide).
Bottom line: Very low toxicity. Main concern is using it as self-treatment for unexplained anemia or neurological symptoms instead of seeking a diagnosis.
Interactions
Long-term metformin use depletes B12 in ~10–30% of patients. Periodic B12 monitoring is reasonable on chronic metformin; dibencozide or any other form will replete deficiency.
Acid suppression reduces protein-bound B12 absorption (food-bound B12 malabsorption). High-dose oral or sublingual B12 bypasses this since the supplemental form is not protein-bound.
Nitrous oxide irreversibly oxidizes cobalt in B12 to the inactive form, depleting body B12 over hours of exposure. Repeated use causes subacute combined degeneration; B12 supplementation (any form) is treatment.
Long-term colchicine can impair B12 absorption modestly. Periodic monitoring on chronic colchicine therapy.
Chloramphenicol can blunt the bone marrow response to B12 repletion in megaloblastic anemia. Rarely co-prescribed in modern practice.
Food sources
| Food | Amount | %DV |
|---|---|---|
| Beef liver | 3 oz | — |
| Sardines | 3 oz | — |
| Salmon | 3 oz | — |
| Eggs | 1 large | — |
Beef liver
- Amount
- 3 oz
- %DV
- —
Sardines
- Amount
- 3 oz
- %DV
- —
Salmon
- Amount
- 3 oz
- %DV
- —
Eggs
- Amount
- 1 large
- %DV
- —
Choosing a product
What to look for on the label — and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Is dibencozide better than methylcobalamin?⌄
Both are active forms of B12 used in different cellular compartments. Head-to-head trials showing meaningful clinical advantages are lacking. Either is fine for most users.
What does dibencozide do?⌄
It is the mitochondrial form of B12, essential for energy production from fats and certain amino acids.
References by claim
Track Dibencozide with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.
Coming to App StoreDisclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.